TCEAL1 and prostate carcinoma: Focussing on Tceal1 as the top hit, LNCaP, DU145, and CWR22 human prostate cancer cell lines were also sensitised to docetaxel treatment upon suppressed TCEAL1 expression (Figs 2E and S3A).